sars-cov-2 variants and mutations
TRANSCRIPT
Thought to make the coronavirus more infectiousAlters the shape of the spike and may helpit evade some antibodiesAlters the shape of the spike and may helpit evade some antibodiesImpacts ability to evade antibody-mediated immunityHelps the virus latch on moHelps the virus latch on more tightly to human cellsPredicted to enhance systemic infection andassociated with increased transmissibility
D614GdelH69V70
delY144
N439KN501YP681H
Key mutations:
First detected: United Kingdom
Alpha (B.1.1.7) B.1.177, B.1.258
May help the virus latch on tighterThought to make the coronavirus more infectiousReduces antibody recognition;Associated with vaccine resistanceHelps the virus bind more tightly to human cellsMay help the virus latch on tighterHelps the virus latch on moHelps the virus latch on more tightly to human cells
D215GD614GE484K
K417NL18FN501Y
Key mutations:First detected: South Africa
Beta (B.1.351) B.1.1.33
Thought to make the coronavirus more infectiousReduces antibody recognition;Associated with vaccine resistanceMay help the virus latch on tighterMay help the virus latch on tighterHelps the virus latch on more tightly to human cellsMay help the virus latch on tighterMay help the virus latch on tighter
Key mutations:
First detected: Brazil (and in Japan, detected in travelers from Brazil)
Gamma (P.1)
May be associated with increased transmissibility;Appears to be very similar to E484K and may beassociated with immune escapeDefining SNP associated with Delta variantMay give an advantage at spreading over other variantsMay help the virus latch on tighter and may resultin in increased transmissibility
*Absence of this mutation in the Delta variant
E484Q*
EFR156-158GL452RP681R
Key mutations:
First detected: India
Delta (B.1.617.2)Kappa (B.1.617.1)B.1.617.3
Reduces antibody recognition;Associated with vaccine resistanceAssociated with variant thatcauses increased transmissibility
L452R
S13I
Key mutations:
First detected: California (USA)
Epsilon (B.1.427/B.1.429)
Potential reduction in neutralizationby some antibody treatments
V1176F
Key mutation:
First detected: Brazil
Zeta (P.2)
Thought to make the coronavirus more infectiousAlters the shape of the spike and may helpit evade some antibodiesReduces antibody recognition;Associated with vaccine resistancePotential reduction in neutralization by someantibody tantibody treatmentsPredicted to enhance systemic infectionand associated with increased transmissibility
D614GdelH69V70
E484K
F888L
P681H
Key mutations:
First detected: United Kingdom/Nigeria
Eta (B.1.525) B.1.1.207
Associated with reduced susceptibility; reducedneutralization by convalescent and post-vaccination seraAssociated with reduced susceptibilityAssociated with reduced susceptibility; reducedneutralization by convalescent and post-vaccination sera
F157S
S477NT95I
Key mutations:
First detected: New York (USA)
Iota (B.1.526)
SNP associated with Mu VOI according to WHOSNP associated with Mu VOI according to WHOSNP associated with Mu VOI according to WHOSNP associated with Mu VOI according to WHOSNP associated with Mu VOI according to WHOAssociated with reduced susceptibility; reducedneutralization by convalescent and post-vaccination seraneutralization by convalescent and post-vaccination sera
A13057T A28272T P5743SR346KT1055AT95I
Key mutations:
First detected: Colombia
Mu (B.1.621)
Thought to make the virus more infectiousD614G
Key mutation:
B.1.1.298 (Mink Variant)
This graphic represents the most up-to-date information as of September 24, 2021.
SARS-CoV-2Variants and mutationsAs SARS-CoV-2 continues to mutate, there are numerous variants popping up around the world. As new variants arise, stay up to datethrough our Notable Variants blog.
We closely track literature and trends to design assaysfor detecting emerging SARS-CoV-2 mutations.Find the most up-to-date list of available assaysat thermofisher.com/mutationpanel
Did you know you can identify each of these key mutations using our TaqMan SARS-CoV-2 Mutation Panel? Create your custom panel
D614GE484K
K417TL18FN501YT20N